PFI 4
Chemical Name: N-[2,3-Dihydro-1,3-dimethyl-2-oxo-6-(1-pyrrolidinyl)-1H-benzimidazol-5-yl]-2-methoxybenzamide
Purity: ≥99%
Biological Activity
PFI 4 is a potent and selective BRPF1B bromodomain inhibitor (IC50 = 172 nM). Exhibits >100-fold selectivity for BRPF1 over a panel of other bromodomains including BRPF2 (BRD1), BRPF3 and BRD4. Disrupts BRPF1 binding to histone H3.3. Cell permeable. Inhibits osteoclastogenesis.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Additional Information
Background References
-
1,3-dimethyl benzimidazolones are potent, selective inhibitors of the BRPF1 bromodomain.
Demont et al.
ACS Med.Chem.Lett., 2014;5:1190 -
Selective targeting of bromodomains of the bromodomain-PHD fingers family impairs osteoclast differentiation.
Meier et al.
ACS Chem.Biol., 2017;12:2619
Product Datasheets
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for PFI 4
There are currently no reviews for this product. Be the first to review PFI 4 and earn rewards!
Have you used PFI 4?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
